Question follow-through · 7594

Migraine: Medical Treatments

To ask the Secretary of State for Health and Social Care, what assessment his Department has made of regional variation in access to CGRP and gepant migraine treatments for patients; and what steps he is taking to ensure that adult neurology waiting lists

answeredDepartment of Health and Social Care

About this written question

A written question asks a government minister for information in writing. Parliament publishes the question and any answer.

Answering body: Department of Health and Social Care
Tabled: 8 Jun 2026
Target answer date: 10 Jun 2026
Answer: 15 Jun 2026 · 7 calendar days after tabling

Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.

Recorded timeline

8 Jun 2026
Question tabled
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of regional variation in access to CGRP and gepant migraine treatments for patients; and what steps he is taking to ensure that adult neurology waiting lists
10 Jun 2026
Target answer date
Date supplied by the official written-questions record.
15 Jun 2026
Answer published
The Department recognises concerns about variation in access to specialist headache services, which can affect the prescribing of newer therapies typically initiated in secondary care.The National Institute for Health and Care Excellence (NICE) has publis...

Open official record

Official data retrieved 28 Sept 2026.

Later records

Possible follow-up questions

Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Stem Cells: Donors

15 Jun 2026 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential implications for national health security of the decline in domestically sourced haematopoietic stem cell (HSC) donations from 42% in 2017/18 to 24% in

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Stem Cells: Donors

15 Jun 2026 · To ask the Secretary of State for Health and Social Care, what steps his department is taking to ensure continuity of haematopoietic stem cell supply for UK patients in the event of a significant disruption to supply.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Stem Cells: Donors

15 Jun 2026 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential financial implications for the NHS of the level of reliance on imported haematopoietic stem cell donations.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Stem Cells: Donors

15 Jun 2026 · To ask the Secretary of State for Health and Social Care, whether the independent review of haematopoietic stem cell supply will include consideration of appointing a single accountable organisation, such as NHS Blood and Transplant, with overall responsi

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Stem Cells: Donors

15 Jun 2026 · To ask the Secretary of State for Health and Social Care, how many minority ethnic and mixed heritage haematopoietic stem cell donors were recruited in each of the years 2022-23, 2023-24, and 2024-25; and what assessment he has made of the potential impli

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Stem Cells: Donors

15 Jun 2026 · To ask the Secretary of State for Health and Social Care, whether he plans to renew or extend the DHSC Stem Cell Programme funding of £400,000 per year to Anthony Nolan and NHS Blood and Transplant respectively for the recruitment of minority ethnic and m

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Stem Cells: Transplant Surgery

15 Jun 2026 · To ask the Secretary of State for Health and Social Care, what data is currently being collected on the impact of patient ethnicity on haematopoietic stem cell transplant outcomes; and what steps he is taking to make such data routinely available.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Stem Cells: Donors

15 Jun 2026 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the trend of decelerating growth in the UK Aligned Stem Cell Registry, and what steps he is taking to reverse that trend.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Stem Cells: Donors

15 Jun 2026 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the reduction in UK donor availability at confirmatory typing.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Stem Cells: Donors

15 Jun 2026 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the underutilisation of cord blood haematopoietic stem cell units in the UK; and what steps he is taking to develop a national strategy for their use within clinical

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Stem Cells: Transplant Surgery

15 Jun 2026 · To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure consistent national adoption of post-transplant cyclophosphamide (PTCy) for patients receiving mismatched unrelated donor haematopoietic stem cell transplants.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Stem Cells: Databases

15 Jun 2026 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the impact of levels of integration in existing data systems across haematopoietic stem cell registries on the ability of clinicians to identify suitable donors in a